|
Showing 1 - 1 of
1 matches in All Departments
Genome- and proteome-based research is generating a significant
increase in the number of available drug targets. Correspondingly
there is an increasing need for novel, diverse compounds,
particularly based on natural compounds, as screening resource. The
purpose of the Ernst Schering Research Foundation Workshop 51 was
to provide a forum for an open exchange on perspectives and
limitations of biocombinatorial synthesis and the significance of
this technology for future drug discovery in light of this
challenge. Experts from academia and industry provided
contributions covering: the significance of natural compounds for
state-of-the-art drug discovery; the underlying basic principle for
the biosynthesis of highly complex compounds; and the scope and
limitations of combinatorial biosynthesis regarding formation,
identification, optimisation, isolation and manufacturing of novel
biologically active entities.
|
You may like...
Gloria
Sam Smith
CD
R407
Discovery Miles 4 070
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.